|Bid||206.30 x 100|
|Ask||208.94 x 100|
|Day's Range||203.69 - 208.21|
|52 Week Range||136.22 - 208.21|
|PE Ratio (TTM)||24.93|
|Forward Dividend & Yield||3.00 (1.48%)|
|1y Target Est||N/A|
The Zacks Analyst Blog Highlights: UnitedHealth, Goldman Sachs, Morgan Stanley, Texas Instruments and Discover Financial.
A U.S. judge is set to hear arguments on Monday about whether to block President Donald Trump's decision to terminate controversial payments to health insurance companies under Obamacare. U.S. District Judge Vince Chhabria in San Francisco federal court has said he would quickly issue a ruling following the hearing. Several U.S. states sued the federal government and asked for an immediate order halting Trump's move while the case is being litigated.
The e-commerce giant reportedly plans to make a decision before Thanksgiving on whether to enter the prescription drug market. Observers weigh in on how its potential entry could impact the landscape.
Stocks hit record highs on IBM, J&J, Adobe and the Senate's step toward tax cuts. Netflix wowed analysts, but investors gave mixed reviews. United Airlines and General Electric plunged.
This could indicate that investors who seek to profit from falling equity prices are not currently targeting UNH. UNH credit default swap spreads are within the middle of their range for the last three years.
To help investors keep up with the markets, we present our ETF Scorecard. The Scorecard takes a step back and looks at how various asset classes across the globe are performing. The weekly performance is from last Friday’s open to this week’s Thursday close.
ETFdb.com analyzes the search patterns of our visitors each week. By sharing these trends with our readers, we hope to provide insights into what the financial world is concerned about and how to position your portfolio.
Anthem plans to launch its own pharmacy-benefit manager, serviced by CVS Health, in 2020 after the conclusion of its contract with Express Scripts.
A bipartisan deal from two senators to stabilize Obamacare by restoring subsidies to health insurers suffered major setbacks on Wednesday with the White House saying President Donald Trump now opposes it and senior Republicans speaking out against it. House of Representatives Speaker Paul Ryan, Senate Finance Committee Chairman Orrin Hatch, Senate Republican leadership member John Thune and others expressed hostility to the deal announced on Tuesday by Republican Lamar Alexander and Democrat Patty Murray.
A U.S. federal judge said on Wednesday he would likely issue a ruling next week on a request from several U.S. states to block President Donald Trump's decision to terminate cost-sharing payments to health ...
Anthem will launch its own pharmacy benefit management business, relying heavily on CVS Health for both back-end processing and retail distribution.
Company stock surged 6.6% in extremely heavy trade, putting it on track for its biggest one-day price gain in 33 years.
As speculation intensifies about a possible entrance by Amazon into the pharmacy business, the insurer says it sees the online giant as a potential distributor of drugs rather than a competitor that could siphon off its prescription benefit management business.
UnitedHealth’s shares gained after it said core insurance and health-services businesses grew in its latest quarter, despite a dent in revenue caused by the company’s decision to pull out of most Affordable ...
Two Senators strike a major deal on crucial health care subsidies. Republican Senator Lamar Alexander and Democratic Senator Patty Murray reached an agreement to extend cost-sharing subsidies to insurance companies. In exchange, some of the law’s requirements will be dropped. The president liked the deal at first but is now backing away from it. Yahoo Finance’s Alexis Christoforous and Jen Rogers figure out why the president isn’t happy with the progress.